Europe Blood Screening Market - Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025
Europe blood screening market is expected to reach with healthy CAGR of 9.3% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Market Segmentation
By Products & Services (Reagents & Kits, Instruments, Software & Services), Technology (Enzyme-Linked Immunosorbent Assay, Rapid Tests, Next-Generation Sequencing, Nucleic Acid Test, Western Blot Assay, Others), Disease Type (Oncology, Diabetes Mellitus, Cold & Flu, Cholesterol, Infectious Diseases, Respiratory Diseases, HIV/AIDS, Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)
Major growing sectors under the market segmentation are as follows:
Market Segmentation
By Products & Services (Reagents & Kits, Instruments, Software & Services), Technology (Enzyme-Linked Immunosorbent Assay, Rapid Tests, Next-Generation Sequencing, Nucleic Acid Test, Western Blot Assay, Others), Disease Type (Oncology, Diabetes Mellitus, Cold & Flu, Cholesterol, Infectious Diseases, Respiratory Diseases, HIV/AIDS, Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)
Major growing sectors under the market segmentation are as follows:
- In products & services, reagents are dominating this market as reagents are majorly used in laboratory, company and other places to perform experiment and also to find or detect the diseases related to human health.
- In technology, enzyme-linked immunosorbent assay (ELISA) is dominating this market as it is more used with accurate result and less costly in the market. It is a versatile tool for physicians, laboratories, and medical professionals all over the world.
- In disease type, oncology is dominating this market as increasing population is detecting more with cancer cases due to exposure to UV lights in today’s world. The Blood screening method is found to be more useful for detecting cancer.
- In end user, diagnostic centers is dominating this market as people mostly prefer diagnostics centers and doctors also suggest patients to visit diagnostics center for detection of diseases.
- Enzo Biochem Inc.
- Meridian Bioscience, Inc.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- BD
- bioMérieux SA
- Beckman Coulter, Inc.
- Abbott
- F. Hoffmann-La Roche Ltd
- Cepheid
- Grifols
- Seimens AG
- Ortho Clinical Diagnostics
- Immucor, Inc.
- Hologic Inc.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE BLOOD SCREENING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 THE CATEGORY VS TIME GRID
2.9 THE CATEGORY VS TIME GRID
2.10 DBMR MARKET CHALLENGE MATRIX
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 RISE IN THE DEMAND OF BLOOD DONATIONS AND BLOOD DONORS
3.1.2 RISING PREVALENCE IN NUMBER OF DISEASES
3.1.3 RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS
3.2 RESTRAINTS
3.2.1 LACK OF USING NAT TECHNLOGY IN EMERGING COUNTRIES
3.2.2 HIGH COST OF TECHNOLOGY AND INSTRUMENTS
3.2.3 EMERGING ALTERNATIVE TECHNOLOGIES
3.3 OPPORTUNITIES
3.3.1 INCREASING MICROBIOLOGY SCREENING & MULTIPLEXING
3.4 CHALLENGES
3.4.1 REDUCTION IN PRICE FOR TECHNOLOGY AND INSTRUMENT
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES
6.1 OVERVIEW
6.2 REAGENTS & KITS
6.2.1 ELISA REAGENTS & KITS
6.2.1.1 IMMUNOSORBENTS
6.2.1.2 CONJUGATES
6.2.1.3 SUBSTRATES
6.2.1.4 CONTROLS
6.2.1.5 SAMPLE DILUENTS AND WASH SOLUTIONS
6.2.2 NAT REAGENTS & KITS
6.2.2.1 PROBES AND PRIMERS
6.2.2.2 ENZYMES AND POLYMERASES
6.2.2.3 LABELING AND DETECTION REAGENTS
6.2.2.4 STANDARDS AND CONTROLS
6.2.2.5 BUFFERS, NUCLEOTIDES AND SOLUTIONS
6.3 INSTRUMENTS
6.3.1.1 INSTRUMENTS, PRODUCT TYPE
6.3.1.1.1 SEMI AUTOMATED
6.3.1.1.2 AUTOMATED
6.3.1.2 INSTRUMENTS, PURCHASE TYPE
6.3.1.2.1 OUTRIGHT PURCHASE
6.3.1.2.2 RENTAL
6.4 SOFTWARE & SERVICES
7 EUROPE BLOOD SCREENING MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
7.2.1 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY PLATFORM
7.2.1.1 COLORIMETRIC IMMUNOASSAY (CI)
7.2.1.2 CHEMILUMINESCENCE IMMUNOASSAY (CLIA)
7.2.1.3 FLUORESCENCE IMMUNOASSAY (FIA)
7.2.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY GENERATIONS
7.2.2.1 FIRST-GENERATION ELISA
7.2.2.2 SECOND-GENERATION ELISA
7.2.2.3 THIRD-GENERATION ELISA
7.2.2.4 FOURTH-GENERATION ELISA
7.3 RAPID TESTS
7.4 NEXT-GENERATION SEQUENCING (NGS)
7.5 NUCLEIC ACID TEST
7.5.1 REAL-TIME POLYMERASE CHAIN REACTION (PCR)
7.5.2 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA)
7.6 WESTERN BLOT ASSAY
7.7 OTHERS
8 EUROPE BLOOD SCREENING MARKET, BY DISEASE TYPE
8.1 OVERVIEW
8.2 ONCOLOGY
8.3 DIABETES MELLITUS
8.4 COLD & FLU
8.5 CHOLESTEROL
8.6 INFECTIOUS DISEASES
8.7 RESPIRATORY DISEASES
8.8 HIV/AIDS
8.9 OTHERS
9 EUROPE BLOOD SCREENING MARKET, BY END USER
9.1 OVERVIEW
9.2 DIAGNOSTIC CENTERS
9.3 BLOOD BANK
9.4 HOSPITALS
9.5 CLINICS
9.6 AMBULATORY SURGICAL CENTERS
10 EUROPE BLOOD SCREENING MARKET, BY GEOGRAPHY
10.1 EUROPE
10.1.1 GERMANY
10.1.2 U.K.
10.1.3 FRANCE
10.1.4 ITALY
10.1.5 SPAIN
10.1.6 SWITZERLAND
10.1.7 NETHERLANDS
10.1.8 BELGIUM
10.1.9 RUSSIA
10.1.10 TURKEY
10.1.11 REST OF EUROPE
11 EUROPE BLOOD SCREENING MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: EUROPE
12 COMPANY PROFILES
12.1 F. HOFFMANN-LA ROCHE LTD
12.1.1 COMPANY OVERVIEW
12.1.2 REVENUEANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENT
12.2 ABBOTT
12.2.1 COMPANY OVERVIEW
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHAREV ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 THERMO FISHER SCIENTIFIC INC.
12.3.1 COMPANY OVERVIEW
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHAREV ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENTS
12.4 SIEMENS AG
12.4.1 COMPANY OVERVIEW
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHAREV ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENTS
12.5 BIO-RAD LABORATORIES, INC.
12.5.1 1.3.1COMPANY OVERVIEW
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHAREV ANALYSIS
12.5.4 PRODUCT PORTFOLIO
12.5.5 RECENT DEVELOPMENTS
12.6 BD
12.6.1 COMPANY OVERVIEW
12.6.2 REVENUE ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 RECENT DEVELOPMENTS
12.7 BECKMAN COULTER, INC.
12.7.1 COMPANY OVERVIEW
12.7.2 GEOGRAPHICPRESENCE
12.7.3 PODUCT PORTFOLIO
12.7.4 RECENET DEVELOPEMENTS
12.8 BIOMÉRIEUX SA
12.8.1 COMPANY OVERVIEW
12.8.2 REVENUE ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 RECENT DEVELOPMENT
12.9 CEPHEID (A SUBSIDIARY OF DANAHER CORPORATION)
12.9.1 COMPANY OVERVIEW
12.9.2 GEOGRAPHIC PRESENCE
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENT
12.10 ENZO BIOCHEM INC.
12.10.1 COMPANY OVERVIEW
12.10.2 REVENUE ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENTS
12.11 GRIFOLS INTERNATIONAL, S.A.
12.11.1 COMPANY OVERVIEW
12.11.2 REVENUE ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENTS
12.12 HOLOGIC INC.
12.12.1 COMPANY OVERVIEW
12.12.2 REVENUE ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENTS
12.13 IMMUCOR, INC.
12.13.1 COMPANY OVERVIEW
12.13.2 GEOGRAPHIC PRESENCE:
12.13.3 PRODUCT PORTFOLIO
12.13.4 RECENT DEVELOPMENTS
12.14 MERIDIAN BIOSCIENCE, INC.
12.14.1 COMPANY OVERVIEW
12.14.2 REVENUE ANALYSIS
12.14.3 PRODUCT PORTFOLIO
12.14.4 RECENT DEVELOPMENTS
12.15 ORTHO CLINICAL DIAGNOSTICS
12.15.1 COMPANY OVERVIEW
12.15.2 GEOGRAPHIC PRESENCE
12.15.3 PRODUCT PORTFOLIO
12.15.4 RECENT DEVELOPMENTS
13 RELATED REPORTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE BLOOD SCREENING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 THE CATEGORY VS TIME GRID
2.9 THE CATEGORY VS TIME GRID
2.10 DBMR MARKET CHALLENGE MATRIX
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 RISE IN THE DEMAND OF BLOOD DONATIONS AND BLOOD DONORS
3.1.2 RISING PREVALENCE IN NUMBER OF DISEASES
3.1.3 RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS
3.2 RESTRAINTS
3.2.1 LACK OF USING NAT TECHNLOGY IN EMERGING COUNTRIES
3.2.2 HIGH COST OF TECHNOLOGY AND INSTRUMENTS
3.2.3 EMERGING ALTERNATIVE TECHNOLOGIES
3.3 OPPORTUNITIES
3.3.1 INCREASING MICROBIOLOGY SCREENING & MULTIPLEXING
3.4 CHALLENGES
3.4.1 REDUCTION IN PRICE FOR TECHNOLOGY AND INSTRUMENT
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES
6.1 OVERVIEW
6.2 REAGENTS & KITS
6.2.1 ELISA REAGENTS & KITS
6.2.1.1 IMMUNOSORBENTS
6.2.1.2 CONJUGATES
6.2.1.3 SUBSTRATES
6.2.1.4 CONTROLS
6.2.1.5 SAMPLE DILUENTS AND WASH SOLUTIONS
6.2.2 NAT REAGENTS & KITS
6.2.2.1 PROBES AND PRIMERS
6.2.2.2 ENZYMES AND POLYMERASES
6.2.2.3 LABELING AND DETECTION REAGENTS
6.2.2.4 STANDARDS AND CONTROLS
6.2.2.5 BUFFERS, NUCLEOTIDES AND SOLUTIONS
6.3 INSTRUMENTS
6.3.1.1 INSTRUMENTS, PRODUCT TYPE
6.3.1.1.1 SEMI AUTOMATED
6.3.1.1.2 AUTOMATED
6.3.1.2 INSTRUMENTS, PURCHASE TYPE
6.3.1.2.1 OUTRIGHT PURCHASE
6.3.1.2.2 RENTAL
6.4 SOFTWARE & SERVICES
7 EUROPE BLOOD SCREENING MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
7.2.1 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY PLATFORM
7.2.1.1 COLORIMETRIC IMMUNOASSAY (CI)
7.2.1.2 CHEMILUMINESCENCE IMMUNOASSAY (CLIA)
7.2.1.3 FLUORESCENCE IMMUNOASSAY (FIA)
7.2.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY GENERATIONS
7.2.2.1 FIRST-GENERATION ELISA
7.2.2.2 SECOND-GENERATION ELISA
7.2.2.3 THIRD-GENERATION ELISA
7.2.2.4 FOURTH-GENERATION ELISA
7.3 RAPID TESTS
7.4 NEXT-GENERATION SEQUENCING (NGS)
7.5 NUCLEIC ACID TEST
7.5.1 REAL-TIME POLYMERASE CHAIN REACTION (PCR)
7.5.2 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA)
7.6 WESTERN BLOT ASSAY
7.7 OTHERS
8 EUROPE BLOOD SCREENING MARKET, BY DISEASE TYPE
8.1 OVERVIEW
8.2 ONCOLOGY
8.3 DIABETES MELLITUS
8.4 COLD & FLU
8.5 CHOLESTEROL
8.6 INFECTIOUS DISEASES
8.7 RESPIRATORY DISEASES
8.8 HIV/AIDS
8.9 OTHERS
9 EUROPE BLOOD SCREENING MARKET, BY END USER
9.1 OVERVIEW
9.2 DIAGNOSTIC CENTERS
9.3 BLOOD BANK
9.4 HOSPITALS
9.5 CLINICS
9.6 AMBULATORY SURGICAL CENTERS
10 EUROPE BLOOD SCREENING MARKET, BY GEOGRAPHY
10.1 EUROPE
10.1.1 GERMANY
10.1.2 U.K.
10.1.3 FRANCE
10.1.4 ITALY
10.1.5 SPAIN
10.1.6 SWITZERLAND
10.1.7 NETHERLANDS
10.1.8 BELGIUM
10.1.9 RUSSIA
10.1.10 TURKEY
10.1.11 REST OF EUROPE
11 EUROPE BLOOD SCREENING MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: EUROPE
12 COMPANY PROFILES
12.1 F. HOFFMANN-LA ROCHE LTD
12.1.1 COMPANY OVERVIEW
12.1.2 REVENUEANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENT
12.2 ABBOTT
12.2.1 COMPANY OVERVIEW
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHAREV ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 THERMO FISHER SCIENTIFIC INC.
12.3.1 COMPANY OVERVIEW
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHAREV ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENTS
12.4 SIEMENS AG
12.4.1 COMPANY OVERVIEW
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHAREV ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENTS
12.5 BIO-RAD LABORATORIES, INC.
12.5.1 1.3.1COMPANY OVERVIEW
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHAREV ANALYSIS
12.5.4 PRODUCT PORTFOLIO
12.5.5 RECENT DEVELOPMENTS
12.6 BD
12.6.1 COMPANY OVERVIEW
12.6.2 REVENUE ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 RECENT DEVELOPMENTS
12.7 BECKMAN COULTER, INC.
12.7.1 COMPANY OVERVIEW
12.7.2 GEOGRAPHICPRESENCE
12.7.3 PODUCT PORTFOLIO
12.7.4 RECENET DEVELOPEMENTS
12.8 BIOMÉRIEUX SA
12.8.1 COMPANY OVERVIEW
12.8.2 REVENUE ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 RECENT DEVELOPMENT
12.9 CEPHEID (A SUBSIDIARY OF DANAHER CORPORATION)
12.9.1 COMPANY OVERVIEW
12.9.2 GEOGRAPHIC PRESENCE
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENT
12.10 ENZO BIOCHEM INC.
12.10.1 COMPANY OVERVIEW
12.10.2 REVENUE ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENTS
12.11 GRIFOLS INTERNATIONAL, S.A.
12.11.1 COMPANY OVERVIEW
12.11.2 REVENUE ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENTS
12.12 HOLOGIC INC.
12.12.1 COMPANY OVERVIEW
12.12.2 REVENUE ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENTS
12.13 IMMUCOR, INC.
12.13.1 COMPANY OVERVIEW
12.13.2 GEOGRAPHIC PRESENCE:
12.13.3 PRODUCT PORTFOLIO
12.13.4 RECENT DEVELOPMENTS
12.14 MERIDIAN BIOSCIENCE, INC.
12.14.1 COMPANY OVERVIEW
12.14.2 REVENUE ANALYSIS
12.14.3 PRODUCT PORTFOLIO
12.14.4 RECENT DEVELOPMENTS
12.15 ORTHO CLINICAL DIAGNOSTICS
12.15.1 COMPANY OVERVIEW
12.15.2 GEOGRAPHIC PRESENCE
12.15.3 PRODUCT PORTFOLIO
12.15.4 RECENT DEVELOPMENTS
13 RELATED REPORTS
LIST OF TABLES
Table 1 LIST OF PRICES FOR FEW DEVICES
Table 2 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025, (USD MILLION)
Table 3 EUROPE REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 4 EUROPE REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 5 EUROPE ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 6 EUROPE NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 7 EUROPE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 8 EUROPE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 9 EUROPE INSTRUMENTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 10 EUROPE SOFTWARE & SERVICES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 11 EUROPE BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 12 EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 13 EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 14 EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY REGION , 2016-2025 (USD MILLION)
Table 15 EUROPE RAPID TESTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 16 EUROPE NEXT-GENERATION SEQUENCING (NGS) IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 17 EUROPE NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 18 EUROPE NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 19 EUROPE WESTERN BLOT ASSAY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 20 EUROPE OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 21 EUROPE BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 22 EUROPE ONCOLOGY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 23 EUROPE DIABETES MELLITUS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 24 EUROPE COLD & FLU IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 25 EUROPE CHOLESTEROL IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 26 EUROPE INFECTIOUS DISEASES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 27 EUROPE RESPIRATORY DISEASESIN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 28 EUROPE HIV/AIDS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 29 EUROPE OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 30 EUROPE BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 31 EUROPE DIAGNOSTIC CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 32 EUROPE BLOOD BANK IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 33 EUROPE HOSPITALS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 34 EUROPE CLINICS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 35 EUROPE AMBULATORY SURGICAL CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 36 EUROPE BLOOD SCREENING MARKET, BY COUNTRY, 2016-2025 (USD MILLION)
Table 37 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 38 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 39 EUROPE ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 40 EUROPE NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 41 EUROPE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 42 EUROPE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 43 EUROPE BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 44 EUROPE NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 45 EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 46 EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 47 EUROPE BLOOD SCREENING MARKET, BY DISEASES TYPE, 2016-2025 (USD MILLION)
Table 48 EUROPE BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 49 GERMANY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 50 GERMANY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 51 GERMANY ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 52 GERMANY NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 53 GERMANY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 54 GERMANY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 55 GERMANY BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 56 GERMANY NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 57 GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 58 GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 59 GERMANY BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 60 GERMANY BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 61 U.K. BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 62 U.K. BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 63 U.K. ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 64 U.K. NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 65 U.K. INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 66 U.K. INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 67 U.K. BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 68 U.K. NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 69 U.K. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 70 U.K. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 71 U.K. BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 72 U.K. BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 73 FRANCE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 74 FRANCE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 75 FRANCE ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 76 FRANCE NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 77 FRANCE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 78 FRANCE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 79 FRANCE BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 80 FRANCE NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 81 FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 82 FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 83 FRANCE BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 84 FRANCE BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 85 ITALY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 86 ITALY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 87 ITALY ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 88 ITALY NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 89 ITALY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 90 ITALY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 91 ITALY BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 92 ITALY NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 93 ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 94 ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 95 ITALY BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 96 ITALY BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 97 SPAIN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 98 SPAIN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 99 SPAIN ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 100 SPAIN NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 101 SPAIN INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 102 SPAIN INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 103 SPAIN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 104 SPAIN NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 105 SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 106 SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 107 SPAIN BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 108 SPAIN BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 109 SWITZERLAND BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 110 SWITZERLAND BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 111 SWITZERLAND ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 112 SWITZERLAND NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 113 SWITZERLAND INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 114 SWITZERLAND INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 115 SWITZERLAND BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 116 SWITZERLAND NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 117 SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 118 SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 119 SWITZERLAND BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 120 SWITZERLAND BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 121 NETHERLANDS BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 122 NETHERLANDS BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 123 NETHERLANDS ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 124 NETHERLANDS NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 125 NETHERLANDS INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 126 NETHERLANDS INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 127 NETHERLANDS BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 128 NETHERLANDS NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 129 NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 130 NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 131 NETHERLANDS BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 132 NETHERLANDS BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 133 BELGIUM BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 134 BELGIUM BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 135 BELGIUM ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 136 BELGIUM NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 137 BELGIUM INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 138 BELGIUM INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 139 BELGIUM BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 140 BELGIUM NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 141 BELGIUM ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 142 BELGIUM ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 143 BELGIUM BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 144 BELGIUM BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 145 RUSSIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 146 RUSSIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 147 RUSSIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 148 RUSSIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 149 RUSSIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 150 RUSSIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 151 RUSSIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 152 RUSSIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 153 RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 154 RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 155 RUSSIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 156 RUSSIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 157 TURKEY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 158 TURKEY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 159 TURKEY ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 160 TURKEY NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 161 TURKEY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 162 TURKEY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 163 TURKEY BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 164 TURKEY NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 165 TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 166 TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 167 TURKEY BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 168 TURKEY BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 169 REST OF EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 1 LIST OF PRICES FOR FEW DEVICES
Table 2 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025, (USD MILLION)
Table 3 EUROPE REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 4 EUROPE REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 5 EUROPE ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 6 EUROPE NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 7 EUROPE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 8 EUROPE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 9 EUROPE INSTRUMENTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 10 EUROPE SOFTWARE & SERVICES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 11 EUROPE BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 12 EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 13 EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 14 EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY REGION , 2016-2025 (USD MILLION)
Table 15 EUROPE RAPID TESTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 16 EUROPE NEXT-GENERATION SEQUENCING (NGS) IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 17 EUROPE NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 18 EUROPE NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 19 EUROPE WESTERN BLOT ASSAY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 20 EUROPE OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 21 EUROPE BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 22 EUROPE ONCOLOGY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 23 EUROPE DIABETES MELLITUS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 24 EUROPE COLD & FLU IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 25 EUROPE CHOLESTEROL IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 26 EUROPE INFECTIOUS DISEASES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 27 EUROPE RESPIRATORY DISEASESIN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 28 EUROPE HIV/AIDS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 29 EUROPE OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 30 EUROPE BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 31 EUROPE DIAGNOSTIC CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 32 EUROPE BLOOD BANK IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 33 EUROPE HOSPITALS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 34 EUROPE CLINICS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 35 EUROPE AMBULATORY SURGICAL CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 36 EUROPE BLOOD SCREENING MARKET, BY COUNTRY, 2016-2025 (USD MILLION)
Table 37 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 38 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 39 EUROPE ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 40 EUROPE NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 41 EUROPE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 42 EUROPE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 43 EUROPE BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 44 EUROPE NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 45 EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 46 EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 47 EUROPE BLOOD SCREENING MARKET, BY DISEASES TYPE, 2016-2025 (USD MILLION)
Table 48 EUROPE BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 49 GERMANY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 50 GERMANY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 51 GERMANY ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 52 GERMANY NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 53 GERMANY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 54 GERMANY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 55 GERMANY BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 56 GERMANY NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 57 GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 58 GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 59 GERMANY BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 60 GERMANY BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 61 U.K. BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 62 U.K. BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 63 U.K. ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 64 U.K. NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 65 U.K. INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 66 U.K. INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 67 U.K. BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 68 U.K. NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 69 U.K. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 70 U.K. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 71 U.K. BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 72 U.K. BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 73 FRANCE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 74 FRANCE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 75 FRANCE ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 76 FRANCE NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 77 FRANCE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 78 FRANCE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 79 FRANCE BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 80 FRANCE NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 81 FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 82 FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 83 FRANCE BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 84 FRANCE BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 85 ITALY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 86 ITALY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 87 ITALY ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 88 ITALY NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 89 ITALY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 90 ITALY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 91 ITALY BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 92 ITALY NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 93 ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 94 ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 95 ITALY BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 96 ITALY BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 97 SPAIN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 98 SPAIN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 99 SPAIN ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 100 SPAIN NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 101 SPAIN INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 102 SPAIN INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 103 SPAIN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 104 SPAIN NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 105 SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 106 SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 107 SPAIN BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 108 SPAIN BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 109 SWITZERLAND BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 110 SWITZERLAND BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 111 SWITZERLAND ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 112 SWITZERLAND NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 113 SWITZERLAND INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 114 SWITZERLAND INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 115 SWITZERLAND BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 116 SWITZERLAND NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 117 SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 118 SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 119 SWITZERLAND BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 120 SWITZERLAND BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 121 NETHERLANDS BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 122 NETHERLANDS BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 123 NETHERLANDS ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 124 NETHERLANDS NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 125 NETHERLANDS INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 126 NETHERLANDS INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 127 NETHERLANDS BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 128 NETHERLANDS NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 129 NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 130 NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 131 NETHERLANDS BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 132 NETHERLANDS BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 133 BELGIUM BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 134 BELGIUM BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 135 BELGIUM ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 136 BELGIUM NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 137 BELGIUM INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 138 BELGIUM INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 139 BELGIUM BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 140 BELGIUM NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 141 BELGIUM ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 142 BELGIUM ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 143 BELGIUM BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 144 BELGIUM BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 145 RUSSIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 146 RUSSIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 147 RUSSIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 148 RUSSIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 149 RUSSIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 150 RUSSIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 151 RUSSIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 152 RUSSIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 153 RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 154 RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 155 RUSSIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 156 RUSSIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 157 TURKEY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 158 TURKEY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 159 TURKEY ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 160 TURKEY NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 161 TURKEY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 162 TURKEY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 163 TURKEY BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 164 TURKEY NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 165 TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 166 TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 167 TURKEY BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 168 TURKEY BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 169 REST OF EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
LIST OF FIGURES
Figure 1 EUROPE BLOOD SCREENING MARKET: SEGMENTATION
Figure 2 EUROPE BLOOD SCREENING MARKET: DATA TRIANGULATION
Figure 3 EUROPE BLOOD SCREENING MARKET: DROC ANALYSIS
Figure 4 EUROPE BLOOD SCREENING MARKET:BOTTOM UP APPROACH
Figure 5 EUROPE BLOOD SCREENING MARKET:TOP DOWN APPROACH
Figure 6 EUROPE BLOOD SCREENING MARKET: INTERVIEW DEMOGRAPHICS
Figure 7 EUROPE BLOOD SCREENING MARKET: DBMR MARKET POSITION GRID
Figure 8 EUROPE BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID
Figure 9 EUROPE BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID
Figure 10 EUROPE BLOOD SCREENING MARKET: THE MARKET CHALLENGE MATRIX
Figure 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE BLOOD SCREENING MARKET
Figure 12 EUROPE BLOOD SCREENING MARKET: SEGMENTATION
Figure 13 RISE IN DEMAND OF BLOOD DONATIONS AND BLOOD DONORS AS WELL AS RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS EXPECTED TO DRIVE THE MARKET FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD 2018 TO 2025
Figure 14 REAGENTS & KITS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BLOOD SCREENING MARKET IN 2018 & 2025
Figure 15 EUROPE BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES, 2017
Figure 16 EUROPE BLOOD SCREENING MARKET: BY TECHNOLOGY, 2017
Figure 17 EUROPE BLOOD SCREENING MARKET: BY DISEASE TYPE, 2017
Figure 18 EUROPE BLOOD SCREENING MARKET: BY END USER, 2017
Figure 19 EUROPE BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 20 EUROPE BLOOD SCREENING MARKET: BY COUNTRY (2017)
Figure 21 EUROPE BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025)
Figure 22 EUROPE BLOOD SCREENING MARKET BY COUNTRY (2017 & 2025)
Figure 23 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025)
Figure 24 ASIA-PACIFIC BLOOD SCREENING MARKET: COMPANY SHARE 2017 (%)
Figure 1 EUROPE BLOOD SCREENING MARKET: SEGMENTATION
Figure 2 EUROPE BLOOD SCREENING MARKET: DATA TRIANGULATION
Figure 3 EUROPE BLOOD SCREENING MARKET: DROC ANALYSIS
Figure 4 EUROPE BLOOD SCREENING MARKET:BOTTOM UP APPROACH
Figure 5 EUROPE BLOOD SCREENING MARKET:TOP DOWN APPROACH
Figure 6 EUROPE BLOOD SCREENING MARKET: INTERVIEW DEMOGRAPHICS
Figure 7 EUROPE BLOOD SCREENING MARKET: DBMR MARKET POSITION GRID
Figure 8 EUROPE BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID
Figure 9 EUROPE BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID
Figure 10 EUROPE BLOOD SCREENING MARKET: THE MARKET CHALLENGE MATRIX
Figure 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE BLOOD SCREENING MARKET
Figure 12 EUROPE BLOOD SCREENING MARKET: SEGMENTATION
Figure 13 RISE IN DEMAND OF BLOOD DONATIONS AND BLOOD DONORS AS WELL AS RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS EXPECTED TO DRIVE THE MARKET FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD 2018 TO 2025
Figure 14 REAGENTS & KITS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BLOOD SCREENING MARKET IN 2018 & 2025
Figure 15 EUROPE BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES, 2017
Figure 16 EUROPE BLOOD SCREENING MARKET: BY TECHNOLOGY, 2017
Figure 17 EUROPE BLOOD SCREENING MARKET: BY DISEASE TYPE, 2017
Figure 18 EUROPE BLOOD SCREENING MARKET: BY END USER, 2017
Figure 19 EUROPE BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 20 EUROPE BLOOD SCREENING MARKET: BY COUNTRY (2017)
Figure 21 EUROPE BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025)
Figure 22 EUROPE BLOOD SCREENING MARKET BY COUNTRY (2017 & 2025)
Figure 23 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025)
Figure 24 ASIA-PACIFIC BLOOD SCREENING MARKET: COMPANY SHARE 2017 (%)
